Hypoxia-induced resistance to cisplatin and doxorubicin in non-small cell lung cancer is inhibited by silencing of HIF-1alpha gene.
about
Chemotherapeutic sensitization of leptomycin B resistant lung cancer cells by pretreatment with doxorubicinHypoxia induces protection against etoposide-induced apoptosis: molecular profiling of changes in gene expression and transcription factor activityPositron emission tomography to assess hypoxia and perfusion in lung cancerKilling hypoxic cell populations in a 3D tumor model with EtNBS-PDTEngineered Nanoparticles Against MDR in Cancer: The State of the Art and its Prospective.Tumor and host factors that may limit efficacy of chemotherapy in non-small cell and small cell lung cancerHypoxia-induced cytotoxic drug resistance in osteosarcoma is independent of HIF-1AlphaPhosphorescence monitoring of hypoxic microenvironment in solid-tumors to evaluate chemotherapeutic effects using the hypoxia-sensitive iridium (III) coordination compoundNrf2 is the key to chemotherapy resistance in MCF7 breast cancer cells under hypoxiaIn vitro optimization of EtNBS-PDT against hypoxic tumor environments with a tiered, high-content, 3D model optical screening platform.Stable tumor vessel normalization with pO₂ increase and endothelial PTEN activation by inositol trispyrophosphate brings novel tumor treatment.Expression of MDR1, HIF-1α and MRP1 in sacral chordoma and chordoma cell line CM-319Prospective neoadjuvant analysis of PET imaging and mechanisms of resistance to Trastuzumab shows role of HIF1 and autophagy.Identification of ATP citrate lyase as a positive regulator of glycolytic function in glioblastomasHIF-1 activation induces doxorubicin resistance in MCF7 3-D spheroids via P-glycoprotein expression: a potential model of the chemo-resistance of invasive micropapillary carcinoma of the breast.Induction of hypoxia-inducible factor-1α inhibits drug-induced apoptosis in the human leukemic cell line HL-60.DNA and histone deacetylases as targets for neuroblastoma treatment.NADPH oxidase-mediated reactive oxygen species production activates hypoxia-inducible factor-1 (HIF-1) via the ERK pathway after hyperthermia treatment.Review of high-dose intravenous vitamin C as an anticancer agent.Single-cell pharmacokinetic imaging reveals a therapeutic strategy to overcome drug resistance to the microtubule inhibitor eribulin.Mitochondrial proteomics with siRNA knockdown to reveal ACAT1 and MDH2 in the development of doxorubicin-resistant uterine cancerIntermediary metabolite precursor dimethyl-2-ketoglutarate stabilizes hypoxia-inducible factor-1α by inhibiting prolyl-4-hydroxylase PHD2.BAY 87-2243, a novel inhibitor of hypoxia-induced gene activation, improves local tumor control after fractionated irradiation in a schedule-dependent manner in head and neck human xenograftsAnti-apoptotic role of HIF-1 and AP-1 in paclitaxel exposed breast cancer cells under hypoxiaPanobinostat reduces hypoxia-induced cisplatin resistance of non-small cell lung carcinoma cells via HIF-1α destabilizationNuclear proteomics with XRCC3 knockdown to reveal the development of doxorubicin-resistant uterine cancer.Near-infrared dye loaded polymeric nanoparticles for cancer imaging and therapy and cellular response after laser-induced heatingExpression of domains for protein-protein interaction of nucleotide excision repair proteins modifies cancer cell sensitivity to platinum derivatives and genomic stability.Identification of proteins responsible for adriamycin resistance in breast cancer cells using proteomics analysis.Carbonic anhydrase IX is a predictive marker of doxorubicin resistance in early-stage breast cancer independent of HER2 and TOP2A amplification.Hypoxia-induced autophagy mediates cisplatin resistance in lung cancer cells.Tumor Hypoxia Response After Targeted Therapy in EGFR-Mutant Non-Small Cell Lung Cancer: Proof of Concept for FMISO-PET.Cancer cell spheroids as a model to evaluate chemotherapy protocols.Automatic assignment of metal-containing peptides in proteomic LC-MS and MS/MS data sets.Label-Free, Longitudinal Visualization of PDT Response In Vitro with Optical Coherence TomographyMicroregional antitumor activity of a small-molecule hypoxia-inducible factor 1 inhibitorValproic acid overcomes hypoxia-induced resistance to apoptosis.Multi-functional nanocarriers to overcome tumor drug resistanceAlterations of microRNA expression patterns in human cervical carcinoma cells (Ca Ski) toward 1'S-1'-acetoxychavicol acetate and cisplatin.Expression and significance of hypoxia-inducible factor-1α and MDR1/P-glycoprotein in laryngeal carcinoma tissue and hypoxic Hep-2 cells.
P2860
Q21134737-B3333212-F4FD-4D27-925C-0AAD4262CAB6Q21245725-DAF8C2FA-F47F-4B41-B71D-819B1BDACDD5Q27026940-DC759C76-E04E-4DE0-AC5A-E3341382D16CQ27324380-3150AA2C-3466-4D35-980B-DD4AEE86B9CEQ28073956-77CD77BC-A37D-4C60-91FD-9B98CB5A357BQ28396304-EA7846EA-0667-417C-A5EA-25DD3AFC6D3DQ28533909-AFAE3D5E-3D62-4A7B-90CB-9FE0F804198CQ28544651-70D558BE-BA51-40D7-BCED-D5450C76B74DQ28828596-8A0F9DFC-9967-46D8-BC78-BC3D6588E0B1Q30531713-2A57CB91-0094-4D99-B4C3-ADC808ECE532Q30540976-9824205D-E90C-4753-B001-BB33E6082317Q33274001-99C54134-37F5-417E-A211-C5F9BE29BACFQ33555302-64A4DC5C-27F1-421E-82E2-350420C07DD7Q33759272-03FB3E24-DF4E-4536-9726-8E9786482D6EQ34118293-85D0FF9F-658C-4AF7-877D-11ED29D4237FQ34316938-373AC470-3CEC-40F5-93E3-CE4E3F6B1DEBQ34320121-445ED2F1-CDE4-40CC-BDA1-69320E69F63AQ34377146-BF0EA846-A836-4A80-8A98-473BB07A326DQ34406887-28290A1A-5A3E-4C26-B95B-CF4BE060DB8DQ34446806-070DDA7B-5CC8-413D-B487-C1D84A6E6712Q34460758-29DD5757-A7E0-4719-A82D-AE19A060831FQ34566270-17169530-1741-4DA1-9F38-4D568313E003Q34672437-5EA49E0C-361C-47A8-8273-6CB7F3E01554Q34992476-394BD4B3-CB16-470E-AEF7-E19FEFE289D8Q35059923-2DC23618-4FCB-4385-8914-9F1DC21C36CCQ35133116-C2922D8E-21B9-448F-8F04-E2E35FA91226Q35159236-DF8DFE85-6E11-4C12-8E6C-1DAA6FEFE52EQ35223337-578D46F1-5181-4585-B099-B7D5CFE271CBQ35227377-A9B1A59C-3243-48B3-AE8B-8A91B16DB57DQ35835151-51F97103-4CEE-441D-B2D3-BC2935252FE9Q35880778-6E006AB7-544D-45DA-8D25-DB88ADA1E281Q36048159-E25C3624-2FA4-4864-AB4D-24463386CC5FQ36312156-2B66AB96-97CE-445B-A9AA-50B196FDDCD5Q36373894-A93EAD32-AA6B-4883-9725-739B0B02948EQ36513863-76AB16C0-BE81-4ED2-95E1-D8D78385ECF7Q36623493-292B9644-CEFB-4590-A27E-50FBBD4399D2Q36642574-17D8458C-4A54-4D03-A8F6-ED06FC709DB9Q36980340-B74ACB2A-25FA-4EC0-98AA-CA6AE1838F58Q37019591-5DAC1447-B565-4996-889B-56B59CCB3898Q37092712-B95D9A8C-70DA-43EA-B829-85170F5D9450
P2860
Hypoxia-induced resistance to cisplatin and doxorubicin in non-small cell lung cancer is inhibited by silencing of HIF-1alpha gene.
description
2006 nî lūn-bûn
@nan
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
2006年论文
@zh
2006年论文
@zh-cn
name
Hypoxia-induced resistance to ...... silencing of HIF-1alpha gene.
@en
type
label
Hypoxia-induced resistance to ...... silencing of HIF-1alpha gene.
@en
prefLabel
Hypoxia-induced resistance to ...... silencing of HIF-1alpha gene.
@en
P2093
P2860
P1476
Hypoxia-induced resistance to ...... silencing of HIF-1alpha gene.
@en
P2093
Jinming Yu
Weiling Chi
Xianrang Song
Xianxi Liu
Xingwu Wang
Yonglei Liu
P2860
P2888
P304
P356
10.1007/S00280-006-0224-7
P577
2006-03-11T00:00:00Z
P6179
1036159909